Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 405174-97-2 | MDL No. : | MFCD07781220 |
Formula : | C6H4BrNO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | DCOPXKMVVJNPSW-UHFFFAOYSA-N |
M.W : | 186.01 | Pubchem ID : | 16414231 |
Synonyms : |
|
Num. heavy atoms : | 9 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 37.32 |
TPSA : | 29.96 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.48 cm/s |
Log Po/w (iLOGP) : | 1.14 |
Log Po/w (XLOGP3) : | 1.34 |
Log Po/w (WLOGP) : | 1.66 |
Log Po/w (MLOGP) : | 0.56 |
Log Po/w (SILICOS-IT) : | 2.2 |
Consensus Log Po/w : | 1.38 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.26 |
Solubility : | 1.01 mg/ml ; 0.00544 mol/l |
Class : | Soluble |
Log S (Ali) : | -1.57 |
Solubility : | 5.0 mg/ml ; 0.0269 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.83 |
Solubility : | 0.278 mg/ml ; 0.00149 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.19 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
99% | With sodium tetrahydroborate In tetrahydrofuran; methanol at 0 - 20℃; for 4 h; | (3-Bromopyridin-2-yl)methanol (B5.2) (0363) To a mixture of B5.1 (1 g, 5.4 mmol) in MeOH (20 mL) and THF (10 mL) was cooled to 0° C., NaBH4 (0.82 g, 21.6 mmol) was added in portions. The mixture was stirred for 4 h at rt. The mixture was concentrated, diluted with water (40 mL), extracted with DCM (40 mL×3), the organic layer was washed with brine, dried over Na2SO4, filtered and concentrated to give the title compound (1 g, 99percent) as a white solid. LC-MS: [M+H]+=190.0. |
99% | With methanol; sodium tetrahydroborate In tetrahydrofuran at 0 - 20℃; for 4 h; | To a mixture of B5.1 (1 g, 5.4 mmol) in MeQH (20 mL) and THF (10 mL) was cooled to 0°C, NaBH4 (0.82 g, 21.6 mmol) wasadded in portions. The mixture was stirred for 4 h at it The mixture was concentrated, diluted with water (40 mL), extracted with DCM (40 mL x 3), the organic layer was washed with brine, dried over Na2SQ4, filtered and concentrated to give the title compound (1 g, 99percent) as a white solid. LC-MS: [M+H] = 190.0. |
82% | With methanol; sodium tetrahydroborate In tetrahydrofuran at 0℃; for 4 h; | A mixture of B6.1 (480 mg, 2.58 mmol ) in MeOH(10 mL) and THF(5 mL) was cooled to 0 oC , NaBH4 (390 mg, 10.32 mmol) was added in portions .The mixture was stirred for 4 h, then concentrated, and diluted with water(30 mL), extracted with DCM (30 mL × 3). The organic layer was washed with brine (30 mL), dried over Na2SO4, concentrated to give the title compound (400 mg, 82percent) as a white solid. LC-MS: [MH]+ = 188.0. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
63% | With selenium(IV) oxide In 1,4-dioxane for 48 h; Reflux | Dissolve 3-bromo-2-methylpyridine (258 mg, 1.5 mmol) in dioxane (5 mL) and add selenium dioxide while stirring (666 mg, 6.0 mmol), the mixture was refluxed for 48 h, allowed to cool, and the filtrate was concentrated. The residue was purified by column chromatography to give a pale yellow solid. (175 mg, 63percent yield). |
55% | With selenium(IV) oxide In 1,4-dioxane at 120℃; for 18 h; | 3-Bromopicolinaldehyde (B5.1) (0362) A mixture of 3-bromo-2-methylpyridine (5 g, 29 mmol), SeO2 (17.5 mg, 116 mmol) in dioxane (70 mL) was heated to 120° C. and stirred for 18 h. The mixture was concentrated and purified by silica gel (PE:EA=4:1) to give the title compound (3 g, 55percent) as a white solid. LC-MS: [M+H]+=188.1. |
55% | With selenium(IV) oxide In 1,4-dioxane at 120℃; for 18 h; | A mixture of 3-bromo-2-methylpyridine (5 g,2gmmol), SeQ2 (17.5 mg, ll6mmol) in dioxane (70 mL) was heated to 120°C andstirred for 18 h. The mixture was concentrated and purified by silica gel (PE:EA = 4:1)to give the title compound (3 g, 55percent) as a white solid. LC-MS: [M+H] = 188.1. |
[ 111043-09-5 ]
1-(3-Bromopyridin-2-yl)ethanone
Similarity: 0.88
[ 30683-23-9 ]
3-Bromopyridine-2-carboxylic acid
Similarity: 0.83
[ 1060815-64-6 ]
3-Bromo-6-chloropicolinaldehyde
Similarity: 0.82
[ 754131-60-7 ]
3-Bromo-2-(bromomethyl)pyridine
Similarity: 0.81
[ 1060815-64-6 ]
3-Bromo-6-chloropicolinaldehyde
Similarity: 0.82
[ 1196157-14-8 ]
4-Bromo-5-methylpicolinaldehyde
Similarity: 0.77
[ 111043-09-5 ]
1-(3-Bromopyridin-2-yl)ethanone
Similarity: 0.88
[ 30683-23-9 ]
3-Bromopyridine-2-carboxylic acid
Similarity: 0.83
[ 1060815-64-6 ]
3-Bromo-6-chloropicolinaldehyde
Similarity: 0.82
[ 754131-60-7 ]
3-Bromo-2-(bromomethyl)pyridine
Similarity: 0.81